W.E. Gutteridge

2.5k total citations
82 papers, 2.0k citations indexed

About

W.E. Gutteridge is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, W.E. Gutteridge has authored 82 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 35 papers in Public Health, Environmental and Occupational Health and 27 papers in Molecular Biology. Recurrent topics in W.E. Gutteridge's work include Trypanosoma species research and implications (41 papers), Research on Leishmaniasis Studies (18 papers) and Malaria Research and Control (18 papers). W.E. Gutteridge is often cited by papers focused on Trypanosoma species research and implications (41 papers), Research on Leishmaniasis Studies (18 papers) and Malaria Research and Control (18 papers). W.E. Gutteridge collaborates with scholars based in United Kingdom, Tanzania and United States. W.E. Gutteridge's co-authors include P. I. Trigg, Mary Pudney, Graham H. Coombs, Craig J. Canfield, Amy Randall, Alan T. Hudson, John J. McCormack, Julian J. Jaffe, John T. Knowler and Jason D. Coombes and has published in prestigious journals such as Nature, Journal of Molecular Biology and Biochemical Journal.

In The Last Decade

W.E. Gutteridge

82 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.E. Gutteridge United Kingdom 23 1.0k 978 811 358 345 82 2.0k
Winston E. Gutteridge United Kingdom 19 779 0.8× 711 0.7× 765 0.9× 191 0.5× 268 0.8× 30 1.7k
Mary Pudney United Kingdom 23 1.0k 1.0× 475 0.5× 542 0.7× 398 1.1× 511 1.5× 45 2.0k
Randolph L. Berens United States 30 983 1.0× 1.5k 1.6× 1.2k 1.4× 465 1.3× 415 1.2× 59 2.3k
Bakela Nare United States 29 944 0.9× 911 0.9× 795 1.0× 427 1.2× 123 0.4× 43 2.1k
Véronique Hannaert Belgium 25 720 0.7× 1.1k 1.1× 1.2k 1.5× 206 0.6× 102 0.3× 37 2.1k
D. C. Warhurst United Kingdom 25 1.3k 1.3× 283 0.3× 559 0.7× 265 0.7× 209 0.6× 72 2.2k
Joanne M. Morrisey United States 24 1.2k 1.2× 378 0.4× 801 1.0× 416 1.2× 263 0.8× 35 2.0k
Danielle Légaré Canada 27 1.6k 1.6× 1.3k 1.3× 477 0.6× 422 1.2× 201 0.6× 37 2.1k
Rentala Madhubala India 32 1.9k 1.9× 1.5k 1.6× 1.2k 1.4× 484 1.4× 144 0.4× 120 3.1k
Gilberto Payares Venezuela 21 873 0.9× 985 1.0× 392 0.5× 494 1.4× 102 0.3× 36 1.7k

Countries citing papers authored by W.E. Gutteridge

Since Specialization
Citations

This map shows the geographic impact of W.E. Gutteridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.E. Gutteridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.E. Gutteridge more than expected).

Fields of papers citing papers by W.E. Gutteridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.E. Gutteridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.E. Gutteridge. The network helps show where W.E. Gutteridge may publish in the future.

Co-authorship network of co-authors of W.E. Gutteridge

This figure shows the co-authorship network connecting the top 25 collaborators of W.E. Gutteridge. A scholar is included among the top collaborators of W.E. Gutteridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.E. Gutteridge. W.E. Gutteridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borrmann, Steffen, Tim Peto, Robert W. Snow, W.E. Gutteridge, & Nicholas J. White. (2008). Revisiting the Design of Phase III Clinical Trials of Antimalarial Drugs for Uncomplicated Plasmodium falciparum Malaria. PLoS Medicine. 5(11). e227–e227. 10 indexed citations
2.
Berman, Jonathan, A.D.M. Bryceson, Simon L. Croft, et al.. (2006). Miltefosine: issues to be addressed in the future. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100. S41–S44. 30 indexed citations
3.
Gutteridge, W.E.. (2006). TDR collaboration with the pharmaceutical industry. Transactions of the Royal Society of Tropical Medicine and Hygiene. 100. S21–S25. 12 indexed citations
4.
Jones, Ian W., et al.. (1996). Nitric oxide synthase activity in malaria‐infected mice. Parasite Immunology. 18(10). 535–538. 17 indexed citations
5.
Canfield, Craig J., Mary Pudney, & W.E. Gutteridge. (1995). Interactions of Atovaquone with Other Antimalarial Drugs against Plasmodium falciparum in Vitro. Experimental Parasitology. 80(3). 373–381. 193 indexed citations
6.
Hudson, Alan T., Maurice Dickins, Colin D. Ginger, et al.. (1991). 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients.. PubMed. 17(9). 427–35. 102 indexed citations
7.
Gutteridge, W.E.. (1989). Parasite vaccines versus anti-parasite drugs: rivals or running mates?. Parasitology. 98(S1). S87–S97. 11 indexed citations
8.
Gutteridge, W.E.. (1989). Pitfalls for research programs involving the rational design of antiparasite drugs. 136. 1 indexed citations
9.
Gutteridge, W.E.. (1988). Chemotherapy of tropical diseases. Transactions of the Royal Society of Tropical Medicine and Hygiene. 82(1). 127–127. 5 indexed citations
10.
Gutteridge, W.E.. (1986). Cervical screening: a do it yourself job for general practice.. BMJ. 292(6518). 451–452. 2 indexed citations
11.
Gutteridge, W.E.. (1985). Molecular biology of host‐parasite interactions. FEBS Letters. 190(1). 178–178. 14 indexed citations
12.
Gutteridge, W.E.. (1983). Molecular Biology of Parasites. FEBS Letters. 164(1). 211–211. 14 indexed citations
13.
Gutteridge, W.E., et al.. (1982). A primary screen for drugs to prevent transmission of Chagas's disease during blood transfusion. Transactions of the Royal Society of Tropical Medicine and Hygiene. 76(5). 633–635. 14 indexed citations
14.
Gull, Keith, et al.. (1980). Micro tubule proteins in ascaridia galli. Parasitology. 81(2). 1 indexed citations
15.
Roitman, Iris, P G Heyworth, & W.E. Gutteridge. (1978). Lipid synthesis byTrichomonas vaginalis. Annals of Tropical Medicine and Parasitology. 72(6). 583–585. 14 indexed citations
16.
Docampo, Roberto, et al.. (1978). Ultrastructural alterations and peroxide formation induced by naphthoquinones in different stages ofTrypanosoma cruzi. Parasitology Research. 57(3). 189–198. 22 indexed citations
17.
Gutteridge, W.E., et al.. (1972). Studies on the biochemistry of the blood and intracellular stages of Trypanosoma cruzi. Preliminary studies on the isolation of intracellular stages from rats. Transactions of the Royal Society of Tropical Medicine and Hygiene. 66(2). 355–355. 2 indexed citations
18.
Gutteridge, W.E.. (1969). Some Effects of Pentamidine Di‐isethionate on Crithidia fasciculata. The Journal of Protozoology. 16(2). 306–311. 35 indexed citations
19.
Gutteridge, W.E., John T. Knowler, & Jason D. Coombes. (1969). Growth of Trypanosoma cruzi in Human Heart Tissue Cells and Effects of Aminonucleoside of Puromycin, Trypacidin and Aminopterin. The Journal of Protozoology. 16(3). 521–525. 56 indexed citations
20.
Gutteridge, W.E.. (1969). Presence and properties of diaminopimelic acid decarboxylases in the genus crithidia. Biochimica et Biophysica Acta (BBA) - General Subjects. 184(2). 366–373. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026